Navigation Links
Global Human Vaccines Industry
Date:5/16/2012

accines: Status As of 2010 II-74International AIDS Vaccine Initiative (IAVI) II-75Cancer II-75Cancer Type and Area Effected II-75Immunotherapies for Cancer II-75Cancer Treatment Drugs II-76Issues Effecting the Development of Commercially ViableCancer Vaccines II-76Frequency of Vaccination II-77Growth Boosters in the Cancer Vaccines Market II-77Available Cancer Treatment Vaccines II-78Select Cancer Vaccines (Therapeutic and Prophylactic) inClinical Trials: As of 2010 II-78Other Cancer Treatment Vaccines II-79Application of Botulinum Toxin as Delivery Mechanism for OralVaccines II-79

6. CLINICAL TRIALS IN THE VACCINES MARKET II-80

Vaccinogen Selects Clinipace for Phase 3b Clinical Trial with

OncoVAX II-80

BioSante to Restart Prostate Cancer Vaccine Clinical Testing II-80

University of Oxford to Commence Phase 2b Proof-of- Concept

Clinical Trials with TB Vaccine in Infants II-80

Emergent Begins Phase I/II Clinical Studies of AIG for

Anthrax Treatment II-81

7. RESEARCH BREAKTHROUGHS - A HISTORIC PERSPECTIVE BUILDER II-82Favrille Announces Phase III Registration Trial Results ofSpecifid in Patients with Follicular B-Cell Non-Hodgkin'sLymphoma II-82Novartis Announces Phase III Results of Menveo® Vaccine II-82Emergent Commences Phase II Clinical Study of Typhoid Vaccine II-82AVANT's Single-Dose Oral Ty800 Vaccine Meets Key Endpoints II-83Emergent BioSolutions' Typhoid Vaccine Completes Final PhaseII Clinical Trial II-83Antigenics Announces Positive Data on Phase-I Study of ACAM-FLU-ATM Vaccine II-83Bavarian Nordic's IMVAMUNE® Post-Exposure VaccinationDemonstrates Protection Against Fatal Poxvirus Infection II-84BSU Scientists to Commence Human West Nile VaccineDevelopment Project II-84Intercell Concludes First Phase Clinical Studies of IC31®Adjuvanted Influenza Vaccine II-84Protherics Commences Phase 2 Angiotensin Vaccine Study II-85Novartis Receives European Approval for Optaflu® Flu Vacci
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... Cannell has joined as Chief Commercial Officer. ... Contrave® /Mysimba™ (naltrexone HCl / bupropion HCl extended ... global commercial strategy, assuming responsibilities previously held by ... commercial effort through the U.S. launch of Contrave, ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... , March 30, 2015  Edison Nation Medical, ... worldwide search for product innovations to assist seniors ... ideas uncovered during the 8-week search will be ... commercialization.  Invention ideas can be submitted through a ... through May 28, 2015. The objective ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... BELL, Pa., Aug. 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: ... ended June 30, 2011. Total revenue was $2.4 million ... 2011, compared to $1.1 million and $2.5 million for the same ... and six months ended June 30, 2011, were $7.6 million and ...
... Aug. 5, 2011 Jury selection in the second trial ... begun in Clark County, Nevada. The Nevada Supreme Court lifted ... it was determined by the court that nurse David Hambrick, ... "does not possess the requisite skill, knowledge or experience to ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs 2
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A key ... neurological diseases plays an important role in the response ... scientists from the Icahn School of Medicine at Mount ... diseases have long been associated with inflammation, part of ... when immune cells home in to attack invaders like ...
(Date:3/30/2015)... Vancouver, BC (PRWEB) March 30, 2015 ... recently announced that the majority of cases taken up ... trial. This means that the lawyers help protect the ... through the tedious court process. The announcement comes across ... their primary job is to provide convenience to their ...
(Date:3/30/2015)... Jose, California (PRWEB) March 30, 2015 ... population and government efforts to develop and establish chronic ... management therapies. Growth in the market is poised to ... as a result of the increase in chronic health ... diseases, and rheumatoid arthritis, among others. While conventional treatment ...
(Date:3/30/2015)... March 30, 2015 On March 19th, ... Field, home of the Detroit Lions, LiveToBeSober.org hosted the ... recognized pastors, ministers and bishops as well as other ... the audience at the luncheon, including retired Detroit Lions ... Per Wickstrom and two survivors of their own personal ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2
... researchers has constructed a model that predicts how an ... airliners. ,The study, "Modeling the Worldwide Spread ... in the January issue of the journal PLoS Medicine. ... world's largest-scale epidemic simulation of its kind. ...
... suggests that TEMPE, a topical anesthetic spray has the ... with premature ejaculation and might be useful// as a ... in the February issue of the urology journal BJU ... studied 54 men with premature ejaculation, randomly assigning them ...
... Rs.350 million to provide health insurance to around 1.2 ... H.D. Kumaraswamy announced// here Wednesday. ,"We are aware ... thousands of families. We have decided to provide health ... has been fixed for the project this year," Kumaraswamy ...
... that a novel needle-free vaccine approach// is effective and ... of Alzheimer’s disease. ,The transdermal, or ... of preventing or treating the devastating neurodegenerative disease with ... ,The study was published online this week in The ...
... effective procedure to combat obesity in adolescents,// according to a ... first study to evaluate the lap band in patients under ... average lost about 50% of their excess weight by one ... issue of the Journal of Pediatric Surgery. Currently, the lap ...
... Women with a history of abuse by intimate partners ... women with no history of such abuse, according to ... plan. ,The higher costs and utilization continued ... Group Health, the University of Washington (UW), and the ...
Cached Medicine News:Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 2Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 3Health News:TEMPE Spray Delays Ejaculation 2Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:Health Care Costs - Significant for Abused Women 2
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....
Medicine Products: